Data as of Apr 17
| +0.015 / +1.17%|
The 2 analysts offering 12-month price forecasts for Acura Pharmaceuticals Inc have a median target of 3.13, with a high estimate of 4.00 and a low estimate of 2.25. The median estimate represents a +141.31% increase from the last price of 1.30.
The current consensus among 1 polled investment analysts is to Buy stock in Acura Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.